- Home
- APOG vs XNCR Comparison
APOG vs XNCR Comparison
Compare APOG & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APOG
- XNCR
- Stock Information
- Founded
- APOG 1949
- XNCR 1997
- Country
- APOG United States
- XNCR United States
- Employees
- APOG N/A
- XNCR N/A
- Industry
- APOG Auto Parts:O.E.M.
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- APOG Consumer Discretionary
- XNCR Health Care
- Exchange
- APOG Nasdaq
- XNCR Nasdaq
- Market Cap
- APOG 1.7B
- XNCR 1.7B
- IPO Year
- APOG N/A
- XNCR 2013
- Fundamental
- Price
- APOG $71.85
- XNCR $24.20
- Analyst Decision
- APOG Hold
- XNCR Strong Buy
- Analyst Count
- APOG 1
- XNCR 9
- Target Price
- APOG $75.00
- XNCR $36.33
- AVG Volume (30 Days)
- APOG 179.0K
- XNCR 850.2K
- Earning Date
- APOG 01-07-2025
- XNCR 11-06-2024
- Dividend Yield
- APOG 1.40%
- XNCR N/A
- EPS Growth
- APOG 4.28
- XNCR N/A
- EPS
- APOG 4.74
- XNCR N/A
- Revenue
- APOG $1,375,510,000.00
- XNCR $85,164,000.00
- Revenue This Year
- APOG N/A
- XNCR N/A
- Revenue Next Year
- APOG $4.80
- XNCR $89.22
- P/E Ratio
- APOG $15.04
- XNCR N/A
- Revenue Growth
- APOG N/A
- XNCR N/A
- 52 Week Low
- APOG $51.15
- XNCR $15.31
- 52 Week High
- APOG $87.93
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- APOG 24.19
- XNCR 44.92
- Support Level
- APOG $71.26
- XNCR $22.74
- Resistance Level
- APOG $81.50
- XNCR $25.54
- Average True Range (ATR)
- APOG 2.15
- XNCR 1.17
- MACD
- APOG -1.38
- XNCR -0.33
- Stochastic Oscillator
- APOG 6.07
- XNCR 22.00
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. Its segments are Architectural Framing Systems; Architectural Glass; Architectural Services and Large-Scale Optical Technologies (LSO). It generates maximum revenue from the Architectural Framing Systems segment. The Architectural Framing Systems segment designs, engineers, fabricates, and finishes the aluminum frames used in customized aluminum and glass windows, curtainwall, storefront, and entrance systems comprising the outside skin and entrances of commercial, institutional, and others. Geographically, it derives a majority of its revenue from the United States.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.